Health and Healthcare
Bristol-Myers (BMY) Looks To Sell Baby Food Business For As Much As $9 Billion
Published:
Bristol-Myers (NYSE: BMY) does not see much future in baby food. It is trying to sell its operation to a company where its is a better fit. According to the FT, that includes Pepsi (NYSE: PEP) and Kraft (NYSE: KFT). BMY wants as much as $9 billion for the business.
The reason behind the sale is that BMY wants to become a specialty drug company, driven by bio-pharmaceuticals. That works unless it doesn’t. There is some advantage to diversity.
Douglas A. McIntyre
Travel Cards Are Getting Too Good To Ignore
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
